Sign In
Buy NHTC
$1.71
+0.0300 (+1.79%)
At Close: Jul 31, 2026
BD's stock gains on launch of rapid COVID-19 diagnostic test
11:43am, Monday, 06'th Jul 2020
Shares of Becton Dickinson & Co. gained 3.6% in premarket trading on Monday after the diagnostics company announced the launch of a point-of-care COVID-19 antigen test that can detect the coronavirus
U.S. regulator greenlights Becton Dickinson's rapid antigen test for COVID-19
11:00am, Monday, 06'th Jul 2020
The U.S. Food and Drug Administration has granted emergency use authorization (EUA) to Becton Dickinson and Co for a COVID-19 antigen test that can be administered at the point of care and produce res
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA)
UK orders 65 mln injection devices from Becton Dickinson for vaccine program
07:00am, Friday, 03'rd Jul 2020
Medical technology company Becton Dickinson and Co said on Friday it received an order from the UK government for 65 million injection devices to support Britain's COVID-19 vaccination program. The o
BD Announces Live Webcast Of Third Fiscal Quarter Earnings Conference Call
08:10pm, Thursday, 02'nd Jul 2020
BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will conduct a live webcast of its third fiscal quarter 2020 earnings conference call on Thursday, August 6, 2020, at 8:00 a.m. (E
A suivre aujourd'hui... IPSEN
06:30am, Thursday, 02'nd Jul 2020
(AOF) - Ipsen va rejoindre la collaboration clinique d'Exelixis et Roche et participera au financement des études pivotales internationales de phase III Contact-01 et Contact-02. L'essai Contact-01 �
IPSEN rejoint une collaboration clinique pour évaluer le cabozantinib
06:15am, Thursday, 02'nd Jul 2020
(AOF) - Ipsen va rejoindre la collaboration clinique d'Exelixis et Roche et participera au financement des études pivotales internationales de phase III Contact-01 et Contact-02. L'essai Contact-01 �
IPSEN : rejoint une collaboration clinique pour évaluer le cabozantinib | Zone bourse
06:14am, Thursday, 02'nd Jul 2020Home, sweet home! - Visually impaired man seizes chance at independence
05:17am, Thursday, 02'nd Jul 2020
“Oh, gosh! I’m blown away!” were the first words uttered by Mark Sweeney shortly after he was presented with the keys to and documents for his new home. Two hundred homes were handed over at Sil
Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY), today announced it will join the Exelixis and Roche clinical collaboration and participate in the
Hedge Funds Never Been Less Bullish On Natural Health Trends Corp. (NHTC)
01:46am, Friday, 05'th Jun 2020
In this article we will check out the progression of hedge fund sentiment towards Natural Health Trends Corp. (NASDAQ:NHTC) and determine whether it is a good investment right now. We at Insider Monke
5 Stocks to Buy for an Uncertain 2020
07:20pm, Thursday, 04'th Jun 2020
With the market finding its way through tricky economic territory, investors will have to strike a careful balance between offensive and defensive moves. These five stocks will help you finesse your a
